bioRxiv · 10.1101/2025.02.25.640208
Endogenous structure of antimalarial target PfATP4 reveals new class of apicomplexan P-type ATPase modulators
Abstract
The Plasmodium falciparum sodium efflux pump PfATP4 is a leading antimalarial target, but suffers from a lack of high-resolution structural information needed to identify functionally important features in conserved regions and guide rational design of next generation inhibitors. Here, we determine a 3.7[A] cryoEM structure of PfATP4 purified from CRISPR-engineered P. falciparum parasites, revealing a previously unknown, apicomplexan-specific binding partner, PfABP, which forms a conserved, likely modulatory interaction with PfATP4. The discovery of PfABP presents a new avenue for designing novel PfATP4 inhibitors.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Haile, M. T., Shukla, A., Zhen, J., Mather, M. W., Bhatnagar, S., Zhang, Z., Vaidya, A. B., Ho, C.-M.. 2025-02-25. Endogenous structure of antimalarial target PfATP4 reveals new class of apicomplexan P-type ATPase modulators. https://doi.org/10.1101/2025.02.25.640208
Cite the original work for its findings. Save a collection to share your selection of sources.